E2F1 and B-cell non-Hodgkin lymphoma: As previously discussed EBNA-3C mediated deregulation of ATM-Chk2 cascade demands further investigation in controlling E2F1-targeted apoptosis in the context of EBV associated B-cell lymphomas.